Treatments for gestational diabetes: A systematic review and meta-analysis

BMJ Open

Volumn 7, Issue 6, 2017, Pages

  Farrar, Diane ^a   Simmonds, Mark ^b   Bryant, Maria ^c   Sheldon, Trevor A ^b   Tuffnell, Derek ^d   Golder, Su ^b   Lawlor, Debbie A ^e  

^a BRADFORD INSTITUTE FOR HEALTH RESEARCH   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d BRADFORD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

gestational diabetes; glibenclamide (glyburide); insulin; meta analysis; metformin; network analysis; packages of care; systematic review; treatments

Indexed keywords

GLIBENCLAMIDE; INSULIN; METFORMIN; ANTIDIABETIC AGENT;

CESAREAN SECTION; DRUG THERAPY; FEMALE; HUMAN; HYPOGLYCEMIA; LARGE FOR GESTATIONAL AGE; LIFESTYLE; META ANALYSIS; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SHOULDER DYSTOCIA; SYSTEMATIC REVIEW; BAYES THEOREM; PREGNANCY; PREGNANCY OUTCOME;

BAYES THEOREM; CESAREAN SECTION; DIABETES, GESTATIONAL; FEMALE; GLYBURIDE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; METFORMIN; PREGNANCY; PREGNANCY OUTCOME; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85021419626     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2016-015557     Document Type: Review

References (82)

1. Alwan N, Tuffnell D, West J, et al. Treatments for gestational diabetes. Cochrane Database of Syst Rev 2009;3:CD003395.
2. Gui J, Liu Q, Feng L. Metformin vs insulin in the management of gestational diabetes: A meta-analysis. PLoS One 2013;8:e64585.
3. Hartling L, Dryden DM, Guthrie A, et al. Benefits and harms of treating gestational diabetes mellitus: A systematic review and metaanalysis for the U. S. Preventive Services Task Force and the National Institutes of Health Office of Medical Applications of Research. Ann Intern Med 2013;159:123-9.
4. Falavigna M, Prestes I, Schmidt MI, et al. Impact of gestational diabetes mellitus screening strategies on perinatal outcomes: A simulation study. Diabetes Res Clin Pract 2013;99:358-65.
5. Horvath K, Koch K, Jeitler K, et al. Effects of treatment in women with gestational diabetes mellitus: Systematic review and metaanalysis. BMJ 2010;340:c1395-413.
6. Balsells M, Garcia-Patterson A, Sola I, et al. Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: A systematic review and meta-analysis. BMJ 2015;350:h102.
7. Han S, Crowther CA, Middleton P, et al. Different types of dietary advice for women with gestational diabetes mellitus. Cochrane Database Syst Rev 2013:CD009275.
8. Jiang YF, Chen XY, Ding T, et al.comparative efficacy and safety of OADs in management of GDM: network meta-analysis of randomized controlled trials. J Clin Endocrinol Metab 2015;100:2071-80.
9. Amin M, Suksomboon N, Poolsup N, et al.comparison of glyburide with metformin in treating gestational diabetes mellitus: A systematic review and meta-analysis. Clin Drug Investig 2015;35:343-51.
10. Kitwitee P, Limwattananon S, Limwattananon C, et al. Metformin for the treatment of gestational diabetes: An updated meta-analysis. Diabetes Res Clin Pract 2015;109:521-32.
11. Zhao LP, Sheng XY, Zhou S, et al. Metformin versus insulin for gestational diabetes mellitus: A meta-analysis. Br J Clin Pharmacol 2015;80:1224-34.
12. Su DF, Wang XY. Metformin vs insulin in the management of gestational diabetes: A systematic review and meta-analysis. Diabetes Res Clin Pract 2014;104:353-7.
13. Zhu B, Zhang L, Fan YY, et al. Metformin versus insulin in gestational diabetes mellitus: A meta-analysis of randomized clinical trials. Ir J Med Sci 2016;185:371-81.
14. Feng Y, Yang H. Metformin-a potentially effective drug for gestational diabetes mellitus: A systematic review and meta-analysis. J Matern Fetal Neonatal Med 2016:1-8.
15. Butalia S, Gutierrez L, Lodha A, et al. Short-and long-term outcomes of metformin compared with insulin alone in pregnancy: A systematic review and meta-analysis. Diabet Med 2017;34:27-36.
16. National Institute for Health and Care Excellence. Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period. National collaborating centre for Women's and Children's Health 2015 https://www.nice. org. uk/guidance/ng3.
17. HigginsJPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5. 1. 0. Cochrane Library, 2011.
18. Centre for Reviews and Dissemination. Systematic reviews: CRD's guidance for undertaking a systematic review York: CRD, University of York, 2009.
19. PRISMA. Preferred reporting items for systematic reviews and metaanalyses. http://www.prisma-statement. org/
20. Farrar D, Simmonds M, Griffin S, et al. The identification and treatment of women with hyperglycaemia in pregnancy: An analysis of individual participant data, systematic reviews, meta-analyses and an economic evaluation. Health Technol Assess 2016;20:1-348.
21. Sakala C, Gyte G, Henderson S, et al. Consumer-professional partnership to improve research: the experience of the Cochrane Collaboration's Pregnancy and Childbirth Group. Birth 2001;28:133-7.
22. The Cochrane Collaboration. The Cochrane Collaboration's tool for assessing risk of bias. http://methods. cochrane. org/bias/assessingrisk-bias-included-studies#The%20Cochrane%20Risk%20of%20 Bias%20Tool (accessed Jan 2014).
23. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
24. Higgins JP, Thompson SG. Quantifying heterogeneity in a metaanalysis. Stat Med 2002;21:1539-58.
25. Bafeta A, Trinquart L, Seror R, et al. Reporting of results from network meta-analyses: methodological systematic review. BMJ 2014;348:g1741.
26. Lumley T. Network meta-analysis for indirect treatment comparisons. Stat Med 2002;21:2313-24.
27. Song F, Altman DG, Glenny AM, et al. Validity of indirect comparison for estimating efficacy of competing interventions: Empirical evidence from published meta-analyses. BMJ 2003;326:472.
28. Mills EJ, Thorlund K, Ioannidis JP. Demystifying trial networks and network meta-analysis. BMJ 2013;346:f2914.
29. Lu G, Ades AE.combination of direct and indirect evidence in mixed treatment comparisons. Stat Med 2004;23:3105-24.
30. openbugs. http://www.openbugs. net/w/FrontPage (accessed Jan 2015).
31. Zinnat ANS, Shareen S, Rahman S. Can metformin be used in place of insulin for the treatment of GDM for low resource countries? BJOG 2013;120:35.
32. Mirzamoradi M, Bakhtiyari M, Kimiaee P, et al. Investigating the effects of treatment based on single high blood glucose in gestational diabetes screening on maternal and neonatal complications. Arch Gynecol Obstet 2015;292:687-95.
33. Deveer R, Deveer M, Akbaba E, et al. The effect of diet on pregnancy outcomes among pregnant with abnormal glucose challenge test. Eur Rev Med Pharmacol Sci 2013;17:1258-61.
34. Fadl HE, Gardefors S, Hjertberg R, et al. Randomized controlled study in pregnancy on treatment of marked hyperglycemia that is short of overt diabetes. Acta Obstet Gynecol Scand 2015;94:1181-7.
35. Yang X, Hsu-Hage B, Dong L, et al. Intensive diabetes management may improve pregnancy. Diabetes Care 2003;26:254-5.
36. Yang X, Tian H, Zhang F, et al. A randomised translational trial of lifestyle intervention using a 3-tier shared care approach on pregnancy outcomes in Chinese women with gestational diabetes mellitus but without diabetes. J Transl Med 2014;12:290.
37. Ma WJ, Huang ZH, Huang BX, et al. Intensive low-glycaemic-load dietary intervention for the management of glycaemia and serum lipids among women with gestational diabetes: A randomized control trial. Public Health Nutr 2015;18.
38. Yao J, Cong L, Zhu B, et al. Effect of dietary approaches to stop hypertension diet plan on pregnancy outcome patients with gestational diabetes mellitus. Bangladesh J Pharmacol 2015;10:732-8.
39. American College of Obstetricians and Gynecologists. Practice bulletin clinical management guidelines for obstetricians-gynecologists. Obstet Gynecol 2013;122:406-16.
40. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: Diagnosis and classification of diabetes mellitus 1999 http://apps. who. int/iris/bitstream/10665/66040/1/WHO- NCD- NCS- 99. 2.pdf.
41. American Diabetes Association. Standards of medical care in diabetes-2014. Diabetes Care 2014;37(Suppl 1):S14-80.
42. Ijas H, Vaarasmaki M, Morin-Papunen L, et al. Metformin should be considered in the treatment of gestational diabetes: A prospective randomised study. BJOG 2011;118:880-5.
43. Tertti K, Ekblad U, Koskinen P, et al. Metformin vs. insulin in gestational diabetes. A randomized study characterizing metformin patients needing additional insulin. Diabetes Obes Metab 2013;15:246-51.
44. Metzger BE, Gabbe SG, Persson B, et al. International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International Association of Diabetes and Pregnancy Study groups recommendations on the diagnosis and classification of hyperglycemia in Pregnancy. Diabetes Care 2010;33:676-82.
45. Bevier WC, Fischer R, Jovanovic L. Treatment of women with an abnormal glucose challenge test (but a normal oral glucose tolerance test) decreases the prevalence of macrosomia. Am J Perinatol 1999;16:269-75.
46. Bonomo M, Corica D, Mion E, et al. Evaluating the therapeutic approach in pregnancies complicated by borderline glucose intolerance: A randomized clinical trial. Diabet Med 2005;22:1536-41.
47. Crowther CA, Hiller JE, Moss JR, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med Overseas Ed 2005;352:2477-86.
48. Elnour AA, El Mugammar IT, Jaber T, et al. Pharmaceutical care of patients with gestational diabetes mellitus. J Eval Clin Pract 2008;14:131-40.
49. Garner P, Okun N, Keely E, et al. A randomized controlled trial of strict glycemic control and tertiary level obstetric care versus routine obstetric care in the management of gestational diabetes: A pilot study. Am J Obstet Gynecol 1997;177:190-5.
50. Landon MB, Spong CY, Thom E, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med Overseas Ed 2009;361:1339-48.
51. Li DF, Wong VC, O'Hoy KM, et al. Is treatment needed for mild impairment of glucose tolerance in pregnancy? A randomized controlled trial. Br J Obstet Gynaecol 1987;94:851-4.
52. O'Sullivan JB, Gellis SS, Dandrow RV, et al. The potential diabetic and her treatment in pregnancy. Obstet Gynecol 1966;27:683-9.
53. Asemi Z, Samimi M, Tabassi Z, et al. The effect of DASH diet on pregnancy outcomes in gestational diabetes: A randomized controlled clinical trial. Eur J Clin Nutr 2014;68:490-5.
54. Cypryk K, Kami?ska P, Kosi?ski M, et al. A comparison of the effectiveness, tolerability and safety of high and low carbohydrate diets in women with gestational diabetes. Endokrynol Pol 2007;58:314-9.
55. Louie JCY, Markovic TP, Perera N, et al. A randomized controlled trial investigating the effects of a low-glycemic index diet on pregnancy outcomes in gestational diabetes mellitus. Diabetes Care 2011;34:2341-6.
56. Moreno-Castilla C, Hernandez M, Bergua M, et al. Low-carbohydrate diet for the treatment of gestational diabetes mellitus: A randomized controlled trial. Diabetes Care 2013;36:2233-8.
57. Rae A, Bond D, Evans S, et al. A randomised controlled trial of dietary energy restriction in the management of obese women with gestational diabetes. Aust N Z J Obstet Gynaecol 2000;40:416-22.
58. Spaulonci CP, Bernardes LS, Trindade TC, et al. Randomized trial of metformin vs insulin in the management of gestational diabetes. Am J Obstet Gynecol 2013;209:34. e1-34. e7.
59. Rowan JA, Hague WM, Gao W, et al. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med Overseas Ed 2008;358:2003-15.
60. Niromanesh S, Alavi A, Sharbaf FR, et al. Metformin compared with insulin in the management of gestational diabetes mellitus: A randomized clinical trial. Diabetes Res Clin Pract 2012;98:422-9.
61. Moore LE, Briery CM, Clokey D, et al. Metformin and insulin in the management of gestational diabetes mellitus: preliminary results of a comparison. J Reprod Med 2007;52:1011-5.
62. Mesdaghinia E, Samimi M, Homaei Z, et al.comparison of newborn outcomes in women with gestational diabetes mellitus treated with metformin or insulin: A randomised blinded trial. Int J Prev Med 2013;4:327-33.
63. Ijas H, Vaarasmaki M, Morin-Papunen L, et al. Metformin should be considered in the treatment of gestational diabetes: A prospective randomised study. BJOG 2011;118:880-5.
64. Hague WM, Davoren PM, Oliver J, et al. Contraindications to use of metformin. Metformin may be useful in gestational diabetes. BMJ 2003;326:762.
65. Hassan JA, Karim N, Sheikh Z. Metformin prevents macrosomia and neonatal morbidity in gestational diabetes. Pak J Med Sci 2012;28:384-9.
66. Ainuddin J, Karim N, Hasan AA, et al. Metformin versus insulin treatment in gestational diabetes in pregnancy in a developing country. A randomized control trial. Diabetes Res Clin Pract 2015;107:290-9.
67. Anjalakshi C, Balaji V, Balaji MS, et al. A prospective study comparing insulin and glibenclamide in gestational diabetes mellitus in Asian Indian women. Diabetes Res Clin Pract 2007;76:474-5.
68. Bertini AM, Silva JC, Taborda W, et al. Perinatal outcomes and the use of oral hypoglycemic agents. J Perinat Med 2005;33:519-23.
69. Lain KY, Garabedian MJ, Daftary A, et al. Neonatal adiposity following maternal treatment of gestational diabetes with glyburide compared with insulin. Am J Obstet Gynecol 2009;200:501. e1-501. e6.
70. Langer O, Conway DL, Berkus MD, et al. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 2000;343:1134-8.
71. Mukhopadhyay P, Bag TS, Kyal A, et al. Oral hypoglycemic glibenclamide: can it be a substitute to insulin in the management of gestational diabetes mellitus? A comparative study. Journal of SAFOG with DVD 2012;4:28-31.
72. Ogunyemi D, Jesse M, Davidson M.comparison of glyburide versus insulin in management of gestational diabetes mellitus. Endocr Pract 2007;13:427-8.
73. Silva J, Bertini A, Taborda W FB, et al. Glibenclamide in the treatment for gestational diabetes mellitus in a compared study to insulin. Arq Bras Endocrinol Metab 2007;51:541-6.
74. Tempe A, Mayanglambam RD. Glyburide as treatment option for gestational diabetes mellitus. J Obstet Gynaecol Res 2013;39:1147-52.
75. Moore LE, Clokey D, Rappaport VJ, et al. Metformin compared with glyburide in gestational diabetes: A randomized controlled trial. Obstet Gynecol 2010;115:55-9.
76. George A, Mathews JE, Sam D, et al.comparison of neonatal outcomes in women with gestational diabetes with moderate hyperglycaemia on metformin or glibenclamide-a randomised controlled trial. Aust N Z J Obstet Gynaecol 2015;55:47-52.
77. Silva JC, Fachin DR, Coral ML, et al. Perinatal impact of the use of metformin and glyburide for the treatment of gestational diabetes mellitus. J Perinat Med 2012;40:225-8.
78. Lawlor DA. The Society for Social Medicine John Pemberton Lecture 2011. Developmental overnutrition-an old hypothesis with new importance? Int J Epidemiol 2013;42:7-29.
79. O'Sullivan JB, Mahan CM. Diabetes 1967;13:278-85.
80. Metzger BE, Lowe LP, Dyer AR, et al. HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358:1991-2002.
81. Farrar D, Fairley L, Santorelli G, et al. Association between hyperglycaemia and adverse perinatal outcomes in South Asian and white British women: Analysis of data from the born in Bradford cohort. Lancet Diabetes Endocrinol 2015;3:795-804.
82. World Health Organization. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. 2013 http://apps. who. int/iris/bitstream/10665/85975/1/WHO- NMH- MND- 13. 2- eng.pdf? ua= 1% 2520% 2520.